Shield Therapeutics Future Growth
Future criteria checks 6/6
Shield Therapeutics is forecast to grow earnings and revenue by 89% and 39.1% per annum respectively. EPS is expected to grow by 77.6% per annum. Return on equity is forecast to be 95% in 3 years.
Key information
89.0%
Earnings growth rate
77.6%
EPS growth rate
Pharmaceuticals earnings growth | 22.8% |
Revenue growth rate | 39.1% |
Future return on equity | 95.0% |
Analyst coverage | Low |
Last updated | 30 Apr 2024 |
Recent future growth updates
No updates
Recent updates
Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
12/31/2026 | 64 | N/A | -9 | N/A | 1 |
12/31/2025 | 89 | 15 | 6 | 15 | 2 |
12/31/2024 | 45 | -14 | -17 | -14 | 2 |
12/31/2023 | 15 | -34 | -37 | -34 | 2 |
6/30/2023 | 7 | -49 | -30 | -28 | N/A |
3/31/2023 | 6 | -49 | -27 | -24 | N/A |
12/31/2022 | 5 | -49 | -23 | -21 | N/A |
9/30/2022 | 4 | -36 | -23 | -20 | N/A |
6/30/2022 | 4 | -30 | -31 | -27 | N/A |
3/31/2022 | 3 | -29 | -29 | -26 | N/A |
12/31/2021 | 2 | -27 | -27 | -25 | N/A |
9/30/2021 | 2 | -22 | -21 | -20 | N/A |
6/30/2021 | 3 | -18 | -16 | -16 | N/A |
3/31/2021 | 9 | -11 | -9 | -9 | N/A |
12/31/2020 | 14 | -4 | -2 | -2 | N/A |
9/30/2020 | 13 | -3 | -1 | -1 | N/A |
6/30/2020 | 11 | -2 | 0 | 0 | N/A |
3/31/2020 | 6 | -6 | -4 | -3 | N/A |
12/31/2019 | 1 | -12 | -7 | -5 | N/A |
9/30/2019 | 8 | -4 | -1 | 1 | N/A |
6/30/2019 | 15 | 3 | 4 | 6 | N/A |
3/31/2019 | 15 | 0 | 0 | 3 | N/A |
12/31/2018 | 15 | -2 | -4 | 0 | N/A |
9/30/2018 | 8 | -13 | -14 | -9 | N/A |
6/30/2018 | 1 | -24 | -24 | -19 | N/A |
3/31/2018 | 1 | -26 | -26 | -21 | N/A |
12/31/2017 | 1 | -26 | -26 | -22 | N/A |
9/30/2017 | 1 | -24 | -25 | -21 | N/A |
6/30/2017 | 0 | -21 | -24 | -19 | N/A |
3/31/2017 | 0 | -19 | N/A | -16 | N/A |
12/31/2016 | 0 | -19 | N/A | -13 | N/A |
9/30/2016 | 0 | -12 | N/A | -12 | N/A |
6/30/2016 | 0 | -4 | N/A | -10 | N/A |
3/31/2016 | 0 | -19 | N/A | -8 | N/A |
12/31/2015 | N/A | -35 | N/A | -6 | N/A |
9/30/2015 | 0 | -41 | N/A | -5 | N/A |
6/30/2015 | 0 | -49 | N/A | -4 | N/A |
3/31/2015 | 0 | -33 | N/A | -5 | N/A |
12/31/2014 | 0 | -20 | N/A | -5 | N/A |
12/31/2013 | 0 | -7 | N/A | -5 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: SHIE.F is forecast to become profitable over the next 3 years, which is considered faster growth than the savings rate (2.4%).
Earnings vs Market: SHIE.F is forecast to become profitable over the next 3 years, which is considered above average market growth.
High Growth Earnings: SHIE.F is expected to become profitable in the next 3 years.
Revenue vs Market: SHIE.F's revenue (39.1% per year) is forecast to grow faster than the US market (8.2% per year).
High Growth Revenue: SHIE.F's revenue (39.1% per year) is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: SHIE.F's Return on Equity is forecast to be very high in 3 years time (95%).